Analyzing the Chemotherapy-Induced Febrile Neutropenia Market Landscape
Chemotherapy-induced febrile neutropenia (CIFN) represents a critical and potentially life-threatening complication observed in cancer patients undergoing chemotherapy. Characterized by fever and a significant reduction in neutrophil count, CIFN compromises the immune system, making patients highly vulnerable to...